Part One of Coventry’s 2017 Drug Trends Series reported the largest drop in Morphine Equivalent Dose (MED) in the last three years. As an indicator of increased chances for adverse outcomes, including death from overdose, these and other inroads are essential in the effort to curtail opioid misuse. To learn more about MED and its impact watch our latest video blog.
More stories
Drug of the Month: Insights Into COVID-19 Vaccines and Workers' Comp
COVID-19 vaccination efforts continue to progress, after the Emergency Use Authorization (EUA) of two COVID-19 vaccines by the Food and Drug Administration (FDA) in late 2020. In late February 2021, a third vaccine was given approval to begin distribution.
Current Used Vehicle Market Conditions: Q4 2020
Average wholesale used vehicle prices fell from their August peak for the fourth month in a row in December, yet finished out the year almost 10% higher than year-ago levels.
COVID—A Year Later
The COVID-19 pandemic has affected many facets of our lives from how we work & live to how we innovate & evolve without truly knowing what lies ahead.
Mitchell Introduces New Alternative for AI-Enabled Claims Processing Through Collaboration with Claim Genius
Company's ongoing expansion of the Mitchell Intelligent Open Platform (MIOP) delivers more AI flexibility to generate damage appraisals.
WorkCompWire: Case Managers Help Alleviate Covid-19’s Head-on Collision with the Opioid Epidemic
As 2020 began, a persistent opioid overdose epidemic was near the forefront of a list of national concerns in the United States.
A chat about long COVID
The Sounding Board recently met with Kate Farley-Agee, our Vice President of Network Products at Coventry, and Tammy Bradly, our Vice President of Clinical Product Development, to talk about the long-term effects that many people who contracted COVID-19 have reported.